Organogenesis Holdings Inc. (ORGO) stock
ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.80−0.01 (-0.86%)
Close on Nov 16, 2026Market cap $103.34MP/E –Yield –
Organogenesis gross margin
Gross margin is gross profit as a percentage of revenue.
Organogenesis's gross margin for the twelve months ending Mar 31, 2025 was 75.9%. For fiscal 2024 it was 76.0%, against 75.4% the year before. The highest annual figure on record is 76.7% in fiscal 2022.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 76.0% | +0.6 |
| FY2023 | Dec 31, 2023 | 75.4% | −1.3 |
| FY2022 | Dec 31, 2022 | 76.7% | +1.1 |
| FY2021 | Dec 31, 2021 | 75.6% | +1.4 |
| FY2020 | Dec 31, 2020 | 74.2% | +3.3 |
| FY2019 | Dec 31, 2019 | 70.9% | +6.5 |
| FY2018 | Dec 31, 2018 | 64.4% | −4.7 |
| FY2017 | Dec 31, 2017 | 69.2% | +3.9 |
| FY2016 | Dec 31, 2016 | 65.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | 72.6% | −1.3 |
| Q4 FY2024 | Dec 31, 2024 | 75.5% | +3.4 |
| Q3 FY2024 | Sep 30, 2024 | 76.7% | +0.5 |
| Q2 FY2024 | Jun 30, 2024 | 77.6% | +0.0 |
| Q1 FY2024 | Mar 31, 2024 | 73.9% | −1.4 |
| Q4 FY2023 | Dec 31, 2023 | 72.1% | −4.4 |
| Q3 FY2023 | Sep 30, 2023 | 76.2% | −1.4 |
| Q2 FY2023 | Jun 30, 2023 | 77.6% | −0.5 |
| Q1 FY2023 | Mar 31, 2023 | 75.3% | +1.1 |
| Q4 FY2022 | Dec 31, 2022 | 76.5% | +2.0 |
| Q3 FY2022 | Sep 30, 2022 | 77.6% | +0.6 |
| Q2 FY2022 | Jun 30, 2022 | 78.0% | +2.3 |
| Q1 FY2022 | Mar 31, 2022 | 74.2% | −1.0 |
| Q4 FY2021 | Dec 31, 2021 | 74.5% | −1.6 |
| Q3 FY2021 | Sep 30, 2021 | 77.0% | −0.2 |
| Q2 FY2021 | Jun 30, 2021 | 75.7% | +4.8 |
| Q1 FY2021 | Mar 31, 2021 | 75.1% | +5.6 |
| Q4 FY2020 | Dec 31, 2020 | 76.1% | +3.4 |
| Q3 FY2020 | Sep 30, 2020 | 77.2% | +7.0 |
| Q2 FY2020 | Jun 30, 2020 | 70.9% | +0.9 |
| Q1 FY2020 | Mar 31, 2020 | 69.6% | −0.7 |
| Q4 FY2019 | Dec 31, 2019 | 72.7% | +0.2 |
| Q3 FY2019 | Sep 30, 2019 | 70.2% | +8.6 |
| Q2 FY2019 | Jun 30, 2019 | 70.1% | +9.8 |
| Q1 FY2019 | Mar 31, 2019 | 70.3% | +11.1 |
| Q4 FY2018 | Dec 31, 2018 | 72.5% | +3.4 |
| Q3 FY2018 | Sep 30, 2018 | 61.6% | −7.1 |
| Q2 FY2018 | Jun 30, 2018 | 60.3% | −11.2 |
| Q1 FY2018 | Mar 31, 2018 | 59.1% | −7.5 |
| Q4 FY2017 | Dec 31, 2017 | 69.1% | – |
| Q3 FY2017 | Sep 30, 2017 | 68.7% | – |
| Q2 FY2017 | Jun 30, 2017 | 71.5% | – |
| Q1 FY2017 | Mar 31, 2017 | 66.6% | – |
See a number that looks wrong?